Literature DB >> 32818703

Negative regulation of IL-8 in human astrocytes depends on β-catenin while positive regulation is mediated by TCFs/LEF/ATF2 interaction.

KaReisha F Robinson1, Srinivas D Narasipura1, Jennillee Wallace1, Ethan M Ritz2, Lena Al-Harthi3.   

Abstract

Expression of cytokines/chemokines is tightly regulated at the transcription level. This is crucial in the central nervous system to maintain neuroimmune homeostasis. IL-8 a chemoattractant, which recruits neutrophils, T cells, and basophils into the brain in response to inflammation and/or injury is secreted predominantly by neurons, microglia, and astrocytes. Here, we investigated the mechanism by which astrocytes regulate IL-8 expression. We demonstrate that while β-catenin negatively regulated IL-8 transcription, its canonical transcriptional partners, members of the TCF/LEF transcription factors (TCF1, TCF3, TCF4 and LEF1) and Activating transcription factor 2 (ATF2) positively regulated IL-8 transcription. We further identified a putative TCF/LEF binding site at -175nt close to the minimal transcription region on the IL-8 promoter, mutation of which caused a significant reduction in IL-8 promoter activity. Chromatin immunoprecipitation demonstrated binding of TCF1, TCF4, LEF1 and ATF2 on the IL-8 promoter suggesting that TCFs/LEF partner with ATF2 to induce IL-8 transcription. These findings demonstrate a novel role for β-catenin in suppression of IL-8 expression and for TCFs/LEF/ATF2 in inducing IL-8. These findings reveal a unique mechanism by which astrocytes tightly regulate IL-8 expression.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrocytes; Neuroinflammation; Wnt signaling; β-catenin

Year:  2020        PMID: 32818703      PMCID: PMC7554258          DOI: 10.1016/j.cyto.2020.155252

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  75 in total

1.  Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.

Authors:  J Roose; G Huls; M van Beest; P Moerer; K van der Horn; R Goldschmeding; T Logtenberg; H Clevers
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

2.  Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice.

Authors:  A M Reimold; J Kim; R Finberg; L H Glimcher
Journal:  Int Immunol       Date:  2001-02       Impact factor: 4.823

Review 3.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

4.  IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoids.

Authors:  Michael R Edwards; Naofumi Mukaida; Malcolm Johnson; Sebastian L Johnston
Journal:  Pulm Pharmacol Ther       Date:  2005-03-17       Impact factor: 3.410

5.  Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production.

Authors:  T Kossmann; P F Stahel; P M Lenzlinger; H Redl; R W Dubs; O Trentz; G Schlag; M C Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  1997-03       Impact factor: 6.200

6.  Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells.

Authors:  Megan F Cole; Sarah E Johnstone; Jamie J Newman; Michael H Kagey; Richard A Young
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

7.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.

Authors:  T Matsusaka; K Fujikawa; Y Nishio; N Mukaida; K Matsushima; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  β-Catenin and TCFs/LEF signaling discordantly regulate IL-6 expression in astrocytes.

Authors:  KaReisha F Robinson; Srinivas D Narasipura; Jennillee Wallace; Ethan M Ritz; Lena Al-Harthi
Journal:  Cell Commun Signal       Date:  2020-06-16       Impact factor: 5.712

9.  β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.

Authors:  Luca Grumolato; Guizhong Liu; Tomomi Haremaki; Sathish Kumar Mungamuri; Phyllus Mong; Gal Akiri; Pablo Lopez-Bergami; Adriana Arita; Youssef Anouar; Marek Mlodzik; Ze'ev A Ronai; Joshua Brody; Daniel C Weinstein; Stuart A Aaronson
Journal:  PLoS Genet       Date:  2013-08-15       Impact factor: 5.917

10.  β-Catenin signaling positively regulates glutamate uptake and metabolism in astrocytes.

Authors:  Victoria Lutgen; Srinivas D Narasipura; Amit Sharma; Stephanie Min; Lena Al-Harthi
Journal:  J Neuroinflammation       Date:  2016-09-10       Impact factor: 8.322

View more
  4 in total

1.  Divergent transcriptional regulation of astrocyte reactivity across disorders.

Authors:  Joshua E Burda; Timothy M O'Shea; Yan Ao; Keshav B Suresh; Shinong Wang; Alexander M Bernstein; Ashu Chandra; Sandeep Deverasetty; Riki Kawaguchi; Jae H Kim; Sarah McCallum; Alexandra Rogers; Shalaka Wahane; Michael V Sofroniew
Journal:  Nature       Date:  2022-05-25       Impact factor: 49.962

Review 2.  Spinal Microglia and Astrocytes: Two Key Players in Chronic Visceral Pain Pathogenesis.

Authors:  Jun-Yi Long; Xue-Jun Wang; Xiao-Ying Li; Xie-He Kong; Guang Yang; Dan Zhang; Yan-Ting Yang; Zheng Shi; Xiao-Peng Ma
Journal:  Neurochem Res       Date:  2021-11-19       Impact factor: 3.996

3.  Occludin facilitates tumour angiogenesis in bladder cancer by regulating IL8/STAT3 through STAT4.

Authors:  Fan Yang; Xue-Qi Liu; Jian-Zhong He; Shi-Ping Xian; Peng-Fei Yang; Zhi-Ying Mai; Miao Li; Ye Liu; Xing-Ding Zhang
Journal:  J Cell Mol Med       Date:  2022-02-27       Impact factor: 5.310

4.  Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders.

Authors:  Christian Scheiber; Tanja Schulz; Julian M Schneider; Karl Bechter; E Marion Schneider
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.